-
December 29, 2009
Corporate deal-making was the name of the big pharma game in 2009 and will likely continue into the new year.
-
December 16, 2009
Chinese companies stole the show in the initial public offering market in 2009, making some lucky (or smart) ...
-
November 18, 2009
Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation ...
-
August 17, 2009
A nice dividend yield shouldn't be the only reason to invest in a company, but it is a nice bonus.
-
July 28, 2009
A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than ...
-
June 19, 2009
Finding undervalued gems can help boost porfolio returns. Check out five potential diamonds in the rough.
-
May 04, 2009
The large cap loser list for April consists of former safe havens that have suffered from investor shifts to sectors ...
-
April 24, 2009
A look at recent merger and acquisition activity in the pharmaceutical sector and possible opportunities if the ...
-
April 23, 2009
There are some signs of a thawing in the IPO market, though investors should not expect a flurry of new activity.
-
April 16, 2009
This has been the quietest IPO period that I can remember, but a smattering of new issues might be seen as ...
-
April 02, 2009
Companies that have exceeded earnings estimates are worthy of further research as analysts' ratings might boost ...
-
March 16, 2009
A company that beats earnings estimates may be on track for solid performance going forward.
-
March 12, 2009
The Merck/Schering marriage might be a winning combination for both the companies and investors.
-
February 25, 2009
Companies with a high forward dividend yield could provide a smile at least four times a year.
-
February 16, 2009
This company's IPO of its Mead Johnson unit will serve as a litmus test for the health of the 2009 equities market.
-
February 12, 2009
Bristol-Myers is among five companies with a great forward annual dividend yield.
-
January 27, 2009
The healthcare industry fell 24.5% in 2008. Abbott fell 4%. Any questions?
-
November 19, 2008
Flush with cash and growth prospects, Bristol makes the case to be a core healthcare holding.
-
November 06, 2008
October was a month for the ages, and there were very few places for investors to hide; read about three stocks that ...
-
October 27, 2008
Forest Labs is facing a lull in its pipeline, but prior lulls have been good buying opportunities.
